Impact of mushroom nutrition on gut microbiota modulation and association with neuroprotective capacity

Helena Araújo-Rodrigues*, Freni Kekhasharú Tavaria, João B. Relvas, Manuela E. Pintado

*Corresponding author for this work

Research output: Contribution to conferencePoster


Alzheimer disease (AD) is a neurodegenerative disorder characterized by a progressive loss of memory and cognitive functions. To date, an effective treatment is not established, but it has been suggested that AD is associated with a decreased level of some microbial-derived products, such as shortchain fatty acids (SCFAs), gamma aminobutyric acid (GABA), and serotonin. Thus, gut microbiota modulation has been proposed as a potential tool for AD prevention and control. Given the importance of diet in this modulation, this PhD program explores the modulatory effect of mushroom biomass nutrition due to their prebiotic, antioxidant, anti-inflammatory, and neuroprotective properties. Regarding this, the direct neuroprotective potential of medicinal and edible mushroom species, as well as their modulatory effect on the production of gut microbiota-related neuroactive metabolites, will be accessed. Their impact through the gut-brain axis on inflammatory brain cells and in AD pathologies will be unrolled to propose novel strategies for preventing or ameliorating this neurological condition.
Original languageEnglish
Publication statusPublished - 16 May 2022
EventCiência 2022: Encontro com a Ciência e Tecnologia em Portugal - Centro de Congressos de Lisboa, Lisboa, Portugal
Duration: 16 May 202218 May 2022


ConferenceCiência 2022


Dive into the research topics of 'Impact of mushroom nutrition on gut microbiota modulation and association with neuroprotective capacity'. Together they form a unique fingerprint.

Cite this